The late Philip S. Low Lab
under the direction of Madduri Srinivasarao
Next Generation Targeted Therapeutics
Research Areas
Phase 3 human clinical trials of Malaria
Bone and Soft Tissue Regeneration
Development of new therapies for malaria
Design of ligand-targeted drugs
Tumor-targeted dyes for fluorescence-guided surgery of cancer
Reprogramming of the Human Immune System
Fluorescence Guided Surgery of Cancer
Design of new therapies for sickle cell disease
Design of targeted anti-viral therapies
Targeted control of cell-based therapeutics
Drug targeting to the tumor microenvironment
Structural characterization of the human red blood cell membrane
Pharmacologic control of neurotransmitter transporters
Radioligand therapies for cancer
SYK-specific tyrosine kinase inhibitors
RNA and DNA-based therapeutics
Therapies for Fibrotic Diseases